0.7256
Oncolytics Biotech Inc (ONCY) 最新ニュース
Oncolytics Biotech Inc. (NASDAQ:ONCY) Sees Significant Increase in Short Interest - MarketBeat
Investors Eye Biotech Sector as Cancer Therapy Market Surges - KamloopsBCNow
Oncolytics Biotech Inc - MENAFN.COM
Oncolytics Biotech advances pancreatic, anal cancer trials - TipRanks
USA News Group: Investors Eye Biotech Sector as Cancer Therapy Market Surges - FinanzNachrichten.de
This AI Stock Is Up 50% in 2025. Is It Too Late to Buy? - The Globe and Mail
Canadian Tire Corporation announces sale of Helly Hansen to Kontoor Brands; simplifying CTC portfolio to focus on Canadian retail growth - The Globe and Mail
Oncolytics Biotech Advances Cancer Trials, Strengthening 2025 Pipeline - TipRanks
Can This Dual Cancer Trial Success Transform Oncolytics' Market Position? - StockTitan
Prediction: Zoom Will Struggle to Beat the Market. Here's Why - The Globe and Mail
Oncolytics Biotech advances in cancer immunotherapy trials By Investing.com - Investing.com Canada
Oncolytics Biotech advances in cancer immunotherapy trials - Investing.com
Clinical Trial Success: Oncolytics' Cancer Drug Shows Superior Results in Two Major Cancer Types - StockTitan
Optimism in War on Cancer on the Rise, as Biotech Companies Roll Out More Wins - Financial Content
Oncolytics Biotech Advances Cancer Treatment Pipeline with Key 2025 Developments - TipRanks
Clinical Breakthrough: Oncolytics' Cancer Drug Shows Remarkable Results in Three Major Cancer Types - StockTitan
Oncolytics Biotech Gets Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency - Marketscreener.com
A closer look at Inhibrx Biosciences Inc (INBX)’s stock price trends - US Post News
Pan American Silver Stock Forecast: Q4 2024 Earnings Preview - The Globe and Mail
Oncolytics Biotech receives Nasdaq non-compliance notice - MSN
Oncolytics Biotech faces Nasdaq delisting over share price - MSN
Oncolytics Biotech® Announces Receipt of Nasdaq Notification Let - GuruFocus.com
Oncolytics Biotech Receives Nasdaq Notification for Bid Price Deficiency - TipRanks
Nasdaq Issues Warning: Oncolytics Biotech Faces Critical 6-Month Deadline to Avoid Delisting - StockTitan
Oncolytics Biotech Announces Leadership Change Amid CEO’s Health Concerns - TipRanks
AMC Networks (AMCX) To Report Earnings Tomorrow: Here Is What To Expect - The Globe and Mail
Oncolytic Virus Therapy Market Growth, Innovations, Demand & - openPR
IGC Pharma Expands Into $75 Billion Wellness Market with the Launch of Holiby(TM) - The Globe and Mail
Oncolytics Biotech Announces Leadership Change Amid CEO Departure - TipRanks
Oncolytics Biotech (TSE:ONC) Shares Up 2.9%Time to Buy? - MarketBeat
Oncolytics Biotech (TSE:ONC) Sets New 1-Year LowHere's Why - MarketBeat
What is HC Wainwright's Estimate for ONCY FY2024 Earnings? - MarketBeat
Oncolytics Biotech® Announces Matt Coffey, Ph.D. Will Not Return to CEO Role Following Medical Leave of Absence - Lelezard
Oncolytics Biotech's Co-Founder CEO Exits: Critical Leadership Change Amid Cancer Drug Development - StockTitan
ONCYOncolytics Biotech, Inc. Common Shares Latest Stock News & Market Updates - StockTitan
Oncolytics Biotech And 2 Other Promising Penny Stocks On The TSX - Simply Wall St
Pre-Op Immunotherapy May Help Treat Aggressive Breast Cancers - 69News WFMZ-TV
FY2029 Earnings Estimate for TSE:ONC Issued By HC Wainwright - MarketBeat
Equities Analysts Offer Predictions for ONCY FY2024 Earnings - Defense World
Oncolytics Biotech (ONCY) Upgraded to Buy: What Does It Mean for the Stock? - MSN
H.C. Wainwright maintains $5 target on Oncolytics Biotech stock - MSN
Can you now get a good deal on Oncolytics Biotech, Inc’s shares? - US Post News
FY2029 Earnings Forecast for ONCY Issued By HC Wainwright - Defense World
FY2029 Earnings Forecast for TSE:ONC Issued By HC Wainwright - Defense World
Oncolytics Biotech (NASDAQ:ONCY) Earns “Buy” Rating from HC Wainwright - Defense World
Financial Metrics Exploration: Understanding Oncolytics Biotech, Inc (ONCY) Through Ratios - The Dwinnex
Brokers Offer Predictions for ONCY FY2029 Earnings - MarketBeat
大文字化:
|
ボリューム (24 時間):